According to an Original Investigation, maternal Tetanus, Diphtheria, and Pertussis Vaccine (Tdap) vaccination reduces pertussis burden in infants (2 months).
The JAMA Pediatrics published the findings of this ecologic study of 57,460 pertussis cases on February 6, 2023, concluding there was a significant difference between pertussis incidence rate differences between the pre–maternal and post–maternal Tdap vaccination periods.
There were about 19,000 cases of pertussis in infants under two months of age during the study period.
Maternal Vaccination Reduces Whopping Cough
COVID-19 Vaccine Protection Lasts at Least Six Months After Second Dose
Vaccine effectiveness against death was lower for patients aged 80 years and older
Next-generation Respiratory Virus Vaccines Need Innovation
Viruses that replicate in the human respiratory mucosa without infecting systemically can cause significant mortality and morbidity and are important public health concerns, wrote a group of health experts, including Dr. Anthony S. Fauci.
Because these viruses, including influenza A, SARS-CoV-2, endemic coronaviruses, RSV, and many other "common cold" viruses, generally do not elicit complete and durable protective immunity by themselves, they have not to date been effectively controlled by licensed or experimental vaccines.
mRNA COVID-19 Vaccines Not Tied to Increases in Guillain-Barré Syndrome
However, the Janssen COVID-19 vaccine was associated with increased risk at 21 and 42 days postvaccination
COVID-19 Leading Cause of Death for U.S. Children, Young People
COVID-19 was among the 10 leading causes of death in CYP aged 0 to 19 during Aug. 1, 2021, to July 31, 2022
COVID-19 Vaccine Primary Series Coverage 76 Percent in Adults 60 Years and Older
Primary series coverage by end of 2022 was below the 100 percent target set for at-risk populations
Pandemic-Linked Decline in Cancer Screening Persisted Into 2022
Low-dose computed tomographic scan rates and mammography rates below expected during March 2021 to February 2022
Mpox Cases Continue Decreasing in 2023
The World Health Organization (WHO) published the Multi-country Mpox outbreak, External situation report #15, confirming Mpox cases recently increased by 716 new cases (0.8%) and nine new related fatalities.
However, reported cases have been steadily declining globally as of February 2, 2023.
From January 2022 through January 30, 2023, a cumulative total of 85,449 laboratory-confirmed cases of mpox and 89 deaths have been reported from 110 countries/territories/areas in all six WHO Regions.
COVID-19 Antiviral Access Expedited
The leading antiviral treatments for a person with either a SARS-CoV-2 coronavirus infection or the disease it causes, COVID-19, became more accessible today.
The U.S. Food and Drug Administration (FDA) notified Pfizer Inc. and Merck Sharp & Dohme LLC on February 1, 2023, it has issued revised emergency Use Authorization (EAU) #105 and #108.
Has Influenza Flown South for Spring Break 2023
As vacationers plan their Spring Break 2023 plans, many ask what happened with this year's flu season.
According to reports recently published by the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC), the 2022-2023 flu season is ending in the Northern Hemisphere.
For example, the WHO's Influenza Update N° 437 concluded countries of North America reported most indicators of influenza activity decreased to levels similar to or below levels typically observed this time of year.